Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017.
Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017.
复制标题
DOI：
10.1016/j.vaccine.2018.03.063
复制
发表时间：
2018-06-18
期刊：
影响因子：
5.5
通讯作者：
Dumolard L
中科院分区：
文献类型：
--
作者：
Lane S;MacDonald NE;Marti M;Dumolard L
了解世卫组织疫苗犹豫定义; >90%的国家报告犹豫。原因清单很长，因国家收入水平而异;世卫组织区域随时间变化。被引用最多的：风险-效益（科学证据）等于引用原因的25%。所列举的理由仅基于1/3国家的评估;需要增加这一比例。为了收集全球疫苗犹豫情况及其是否/如何发生变化，进行了一项分析，以审查截至2017年6月来自世卫组织/联合国儿童基金会联合报告表（JRF）的三年可用数据，以确定地球仪报告的疫苗犹豫率，所引用的犹豫原因，这些原因是否因国家收入水平和/或世卫组织区域而异，以及这些原因是否基于评估。报告的原因使用免疫接种战略咨询专家组犹豫决定因素矩阵进行分类（www.who.int/immunization/sage/meetings/2014/WEBER/SAGE_working_group_revised_report_vaccine_hesitancy.pdf）。犹豫不决很常见，超过90%的国家报告了这一情况。所列举的原因很长，涵盖了世卫组织决定因素矩阵23个类别中的22个。即使是最常被引用的类别，即风险-效益（科学证据，例如疫苗安全问题），也只占所引用的所有原因的不到四分之一。原因因国家收入水平、世卫组织区域、时间和国家内部而异。因此，根据JRF的数据，地球仪各国似乎理解SAGE疫苗犹豫定义，并使用该定义报告犹豫原因。然而，所列举理由的严谨性还有待提高，因为只有略多于三分之一的国家报告说，其理由是基于评估，其余的是基于意见。关于过去五年的任何评估，中上收入国家最不可能进行评估。这些分析为《2017年全球疫苗行动计划评估报告》提供了一些证据，该报告建议各国制定一项战略，以增加对疫苗接种的接受和需求，其中应包括持续的社区参与和信任建设，积极预防犹豫，定期对疫苗问题进行国家评估，和危机应对规划（www.who.int/immunization/sage/meetings/2017/pager/1_GVAP_Assessment_report_web_version.pdf）。
WHO vaccine hesitancy definition understood; >90% countries report hesitancy. Long list of reasons, varied by country income level; WHO region, changed overtime. Most cited: risk-benefit (scientific evidence) equaled <25% of reasons cited. Reasons cited based on assessments in only 1/3 of countries; need to increase this. In order to gather a global picture of vaccine hesitancy and whether/how it is changing, an analysis was undertaken to review three years of data available as of June 2017 from the WHO/UNICEF Joint Report Form (JRF) to determine the reported rate of vaccine hesitancy across the globe, the cited reasons for hesitancy, if these varied by country income level and/or by WHO region and whether these reasons were based upon an assessment. The reported reasons were classified using the Strategic Advisory Group of Experts (SAGE) on Immunization matrix of hesitancy determinants (www.who.int/immunization/sage/meetings/2014/october/SAGE_working_group_revised_report_vaccine_hesitancy.pdf). Hesitancy was common, reported by >90% of countries. The list of cited reasons was long and covered 22 of 23 WHO determinants matrix categories. Even the most frequently cited category, risk- benefit (scientific evidence e.g. vaccine safety concerns), accounted for less than one quarter of all reasons cited. The reasons varied by country income level, by WHO region and over time and within a country. Thus based upon this JRF data, across the globe countries appear to understand the SAGE vaccine hesitancy definition and use it to report reasons for hesitancy. However, the rigour of the cited reasons could be improved as only just over 1/3 of countries reported that their reasons were assessment based, the rest were opinion based. With respect to any assessment in the previous five years, upper middle income countries were the least likely to have done an assessment. These analyses provided some of the evidence for the 2017 Assessment Report of the Global Vaccine Action Plan recommendation that each country develop a strategy to increase acceptance and demand for vaccination, which should include ongoing community engagement and trust-building, active hesitancy prevention, regular national assessment of vaccine concerns, and crisis response planning (www.who.int/immunization/sage/meetings/2017/october/1_GVAP_Assessment_report_web_version.pdf).
影响因子：
5.5
作者：
Butler, Robb;MacDonald, Noni E.
通讯作者：
MacDonald, Noni E.
影响因子：
5.5
作者：
MacDonald, Noni E.
通讯作者：
MacDonald, Noni E.
影响因子：
3.7
作者：
Marti M;de Cola M;MacDonald NE;Dumolard L;Duclos P
通讯作者：
Duclos P